Related Experiment Video
Updated: Oct 1, 2026

Biaxial Basal Tone and Passive Testing of the Murine Reproductive System Using a Pressure Myograph
Published on: August 13, 2019
ECT During Pregnancy: Physiologic and Pharmacologic Considerations
Mary J. Ferrill1, William A. Kehoe, John J. Jacisin
1University of the Pacific, Stockton, and Modesto Psychiatric Center, Modesto, California, USA.
Abstract:
ECT is an accepted treatment for depression, mania, catatonia, and schizophrenia, but is usually used after other traditional drug treatments have failed. This also holds true for pregnant women who require psychiatric treatment. ECT is normally deferred until the fetus is at risk from the unstable psychiatric condition of the mother. This review examines the physiological effects of ECT, case reports of pregnant women receiving ECT, and possible complications of the medications administered before the procedure. All published case reports of ECT during all trimesters of pregnancy and the effects of ECT on the child are reviewed. The medications given before ECT (i.e., anticholinergics, muscle relaxants, and anesthetics) are examined for their teratogenic potential when administered multiple times during pregnancy.
Related Concept Videos
Adrenergic Antagonists: ɑ and β-Receptor Blockers
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by anesthetizing...
Teratogenicity
Hormonal Regulation
Pharmacodynamic Responses: Different Types
Factors Affecting Drug Response: Overview